Risedronic acid
99%
- Product Code: 122186
Alias:
Risedronate (sodium); Risedronate; Risedronate; Risedronate-D4
CAS:
105462-24-6
| Molecular Weight: | 283.11 g./mol | Molecular Formula: | C₇H₁₁NO₇P₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 171.7℃ | |
| Density: | Storage Condition: | 2~8°C |
Product Description:
Risedronic acid is primarily used in the treatment of bone-related disorders, particularly osteoporosis in postmenopausal women and men. It helps to increase bone mass and reduce the risk of fractures by inhibiting bone resorption. Additionally, it is effective in managing Paget's disease, a condition characterized by abnormal bone remodeling. The medication is also prescribed to prevent bone loss in patients undergoing long-term corticosteroid therapy. It is typically administered orally in tablet form, with specific instructions to ensure optimal absorption and minimize gastrointestinal side effects. Regular monitoring of bone density and kidney function is recommended during treatment.
Product Specification:
| Test | Specification |
|---|---|
| Purity (%) | 99-100 |
| Appearance | White Powder |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | $12.98 |
+
-
|
| 5.000 | 10-20 days | $46.40 |
+
-
|
| 25.000 | 10-20 days | $176.57 |
+
-
|
| 100.000 | 10-20 days | $672.08 |
+
-
|
Risedronic acid
Risedronic acid is primarily used in the treatment of bone-related disorders, particularly osteoporosis in postmenopausal women and men. It helps to increase bone mass and reduce the risk of fractures by inhibiting bone resorption. Additionally, it is effective in managing Paget's disease, a condition characterized by abnormal bone remodeling. The medication is also prescribed to prevent bone loss in patients undergoing long-term corticosteroid therapy. It is typically administered orally in tablet form, with specific instructions to ensure optimal absorption and minimize gastrointestinal side effects. Regular monitoring of bone density and kidney function is recommended during treatment.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :